NATURE’S SUNSHINE PRODUCTS, INC. Increase (Decrease) in Restricted Cash for Operating Activities
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Increase (Decrease) in Restricted Cash for Operating Activities of -$747.00 thousand for the 12-month period ending 2010-12-31, per its 10-K filed 2013-03-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities · last filed 2013-03-07
- NATURE’S SUNSHINE PRODUCTS, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2010-12-31 was -$250.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2010-09-30 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. increase (decrease) in restricted cash for operating activities for fiscal 2010 was -$747.00K.
| Period end | Increase (Decrease) in Restricted Cash for Operating Activities 3 month | Increase (Decrease) in Restricted Cash for Operating Activities 6 month | Increase (Decrease) in Restricted Cash for Operating Activities 9 month | Increase (Decrease) in Restricted Cash for Operating Activities 12 month |
|---|---|---|---|---|
| 2010-12-31 | -$250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | -$250.00K derived: sum of 2 quarters · filed 2013-03-07 | -$747.00K 10-K · filed 2013-03-07 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$497.00K 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | -$497.00K 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |